Saturday, September 21, 2019
Tags Clinical trials

Tag: clinical trials

Patient organization challenges government to bring vital support to people with...

Madrid, Spain, 14 June 2019: The campaign presented today at the Annual European Congress of Rheumatology (EULAR 2019) reports how the Cyprus League Against...

Tildrakizumab shows promising efficacy and safety in psoriatic arthritis

Madrid, Spain, 14 June 2019: The results of a phase 2B study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate...

Inflammatory bowel disease and type I diabetes increase chances of developing...

Annual European Congress of Rheumatology (EULAR 2019) Madrid, Spain, 12-15 June 2019Madrid, Spain, 14 June 2019: The results of a study presented today at...

Study reveals significant gaps in essential rheumatoid arthritis care across Europe...

Madrid, Spain, 14 June 2019: The results of a large pan-European survey presented today at the Annual European Congress of Rheumatology (EULAR 2019) investigated...

Vagus nerve stimulation study shows significant reduction in rheumatoid arthritis symptoms

Annual European Congress of Rheumatology (EULAR 2019) Madrid, Spain, 12-15 June 2019Madrid, Spain, 14 June 2019: The results of a pilot study presented today...

Please see special handling

A personalised active lifestyle programme for employees with metabolic syndrome (who are at high risk of heart disease, stroke, and type 2 diabetes) that...

Carboplatin & paclitaxel chemotherapy alone should remain standard treatment for endometrial...

The New England Journal of Medicine recently published the primary endpoint of the NRG Oncology clinical trial NRG-GOG 0258, which showed that carboplatin and...

Common conditions keep many patients out of knee cartilage research studies

Some of the most common traits among patients with cartilage issues in the knee are excluding them from participating in clinical trials because the...

Phase 3 topline data for ULTOMIRISu00ae (ravulizumab) in aHUS presented at...

BOSTON -- (EUREKALERT!) -- Alexion Pharmaceuticals, Inc. today announced the first conference presentation of the topline Phase 3 data for ULTOMIRIS ® (ravulizumab), the...

New biomarkers for cardiovascular risk in patients with juvenile-onset systemic lupus...

Annual European Congress of Rheumatology (EULAR 2019) Madrid, Spain, 12-15 June 2019Madrid, Spain, 13 June 2019: The results of a study presented today at...